Use of Biomarkers in Ongoing Research Protocols on Alzheimer’s Disease

Use of Biomarkers in Ongoing Research Protocols on Alzheimer’s Disease

The present study aimed to describe and discuss the state of the art of biomarker use in ongoing Alzheimer’s disease (AD) research. A review of 222 ongoing phase 1, 2, 3, and 4 protocols registered in the clinicaltrials.gov database was performed. All the trials (i) enrolling subjects with clinical...

Full description

Bibliographic Details
Main Authors: Marco Canevelli, Giulia Remoli, Ilaria Bacigalupo, Martina Valletta, Marco Toccaceli Blasi, Francesco Sciancalepore, Giuseppe Bruno, Matteo Cesari, Nicola Vanacore
Format: Article
Language:English
Published: MDPI AG 2020-07-01
Series:Journal of Personalized Medicine
Subjects:
Alzheimer’s disease
biomarkers
drug development
clinical trials
diagnostic research
Online Access:https://www.mdpi.com/2075-4426/10/3/68

Internet

https://www.mdpi.com/2075-4426/10/3/68

Similar Items